The annual Symposium on Substance Use Research (SOSUR) focuses on leveraging research, knowledge, and insight on substance use from across the country. This year, it was held on November 08-10, via Zoom. The virtual format included expert keynotes, panels, and research presentations on a wide variety of substance use topics (see below for the agenda.) There was no cost to attend and it was open to the public.
2022 SOSUR was co-hosted by:
- the Rural Drug Addiction Research (RDAR) COBRE
- the COBRE on Opioids and Overdose
- the West Virginia Clinical and Translational Science Institute (WVCTSI)
- the West Virginia INBRE (WV-INBRE) at Marshall University
- the COBRE Center for Addiction and Disease Risk Exacerbation (CADRE) at Brown University
The Symposium Agenda
Pre-Symposium Activities: Tuesday, November 8th
12:30pm – 1:30pm CT (1:30pm – 2:30pm ET)
Pre-Symposium Workshop: Grant Writing Tips and Q&A with Experienced Investigators
The panel will discuss writing strategies, understanding all components of a Research Funding Proposal (RFA), how to approach a program officer with questions, and other aspects of preparing a grant proposal.
Day One: Wednesday, November 9th
9:00am – 10:00am CT (10:00am – 11:00am ET)
Keynote 1:
Michael Taffe, PhD | "An Update on Racial Inequities in NIH Grant Funding"
This keynote presentation will overview the persisting disparity in NIH grant award funding, that leaves proposals submitted by Black Principal Investigators at a substantial disadvantage. The talk will address how this has been shown to lead to a disparity in which topics of research are funding and how this may contribute to the underfunding of research on critical health questions that are of interest to non-majority populations. Dr. Michael Taffe is a Professor in the Department of Psychiatry and the Skaggs School of Pharmacy at the University of California, San Diego.
10:30am – 11:30am CT (11:30am – 12:30pm ET)
Rapid-Fire Poster Session
This was an energetic, fast-paced session showcasing a multitude of projects in substance use research.
12:30pm – 1:30pm CT (1:30pm – 2:30pm ET)
Panel Discussion on How to Publish a Journal Manuscript
The panel will discuss how best to prepare your manuscript for review, select relevant journals, respond to feedback during the peer-review process, and ways to increase efficiency throughout the process.
Day Two: Thursday, November 10th
9:00am – 10:00am CT (10:00am – 11:00am ET)
Keynote 2:
Yasmin Hurd, PhD | "Neurobiological Pathways to Addiction to Drive Novel Treatment Interventions"
The continued opioid epidemic highlights the important need for the development of novel non-addictive, non-opioid medications. This talk will provide molecular knowledge gained from post-mortem studies of human heroin users and complementary mechanistic animal studies that identify specific epigenetic and glutamatergic signaling marks that may offer druggable targets for opioid use disorder. Moreover, the talk will consider preclinical and clinical translational studies of CBD being considered for the treatment of opioid use disorder. Dr. Yasmin Hurd is a Professor of Psychiatry and the Director for the Addiction Institute at the Icahn School of Medicine at Mount Sinai in New York.
10:30am – 11:30am CT (11:30am – 12:30pm ET)
Short Research Presentations
12:30pm – 1:30pm CT (1:30pm – 2:30pm ET)
Panel Discussion on Promotion and Tenure
This panel discussion will focus on the promotion and tenure (P/T) process for basic science and clinical faculty engaging in addiction research.
This event is supported by the Rural Drug Addiction Research COBRE at the University of Nebraska-Lincoln [P20GM130461], the COBRE on Opioids and Overdose at Rhode Island Hospital [P20GM125507], the West Virginia Clinical and Translational Science Institute [5U54GM104942], the WV-INBRE at Marshall University [P20GM103434], and the COBRE Center for Addiction and Disease Risk Exacerbation at Brown University [P20GM130414]. All are funded by the National Institute of General Medical Sciences of the National Institutes of Health.
This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.